Revolution Medicines, Inc. Warrant(RVMDW)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic ag…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +3.92% 3
Feb +3.08% 3
Mar -23.62% 3
Apr +99.25% 3
May -19.83% 3
Jun +15.22% 3
Jul +56.07% 2
Aug -28.74% 2
Sep +75.42% 2
Oct +12.98% 2
Nov +40.29% 3
Dec -12.92% 3
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $5.77
SMA 50: $4.98
SMA 200: $2.06
Current: $5.94
EMA 12: $5.72
EMA 26: $5.53
MACD: 0.1953 | Signal: -0.1169
BULLISH
ADX (14): 32.16
TREND
+DI: 26.71
−DI: 19.83
Momentum Oscillators
RSI (14): 54.57
NEUTRAL
Stoch %K: 30.95
Stoch %D: 24.68
Williams %R: -52.12
Volume & Volatility
BB Upper: $6.66
BB Lower: $4.88
NEUTRAL
OBV: 7,214,003
Vol SMA 20: 74,158
Vol ROC: -27.39%
ATR: $0.65
True Range: $0.60
HV 20: 121.7%
HV 30: 116.9%
HV 60: 214.6%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:17.529000
Date Range: 2024-03-12T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
Loading options activity...
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
3.56
Correlation (SPY)
18.2%
0.03
Ann. Volatility
241.5%
SPY Volatility
12.3%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

22 filers10,034,944 shares$16.90M value
# Filer Shares Value % of Total % of Float Period
1 LMR Partners LLP 3,838,024 $6.87M 40.66% 2026-03-31
2 D. E. Shaw & Co., Inc. Custodian 1,580,345 $2.75M 16.28% 2026-03-31
3 Sculptor Capital LP 958,822 $1.70M 10.04% 2026-03-31
4 ARISTEIA CAPITAL, L.L.C. 583,615 $1.03M 6.11% 2026-03-31
5 Caption Management, LLC 517,685 $926.66K 5.48% 2026-03-31
6 ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000 $895.00K 5.30% 2026-03-31
7 Lunate Capital Ltd 450,000 $805.50K 4.77% 2026-03-31
8 PERCEPTIVE ADVISORS LLC 250,000 $447.50K 2.65% 2026-03-31
9 Bleichroeder LP 200,000 $358.00K 2.12% 2026-03-31
10 WOLVERINE ASSET MANAGEMENT LLC 170,698 $305.55K 1.81% 2026-03-31
11 CSS LLC/IL 17,505 $281.77K 1.67% 2026-03-31
12 DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 150,000 $261.00K 1.54% 2026-03-31
13 Weiss Asset Management LP 73,640 $128.13K 0.76% 2026-03-31
14 TD ASSET MANAGEMENT INC 40,636 $70.71K 0.42% 2026-03-31
15 DRIEHAUS CAPITAL MANAGEMENT LLC 20,000 $34.80K 0.21% 2026-03-31
16 TORONTO DOMINION BANK 10,000 $17.90K 0.11% 2026-03-31
17 HRT FINANCIAL LP 92,800 $9.02K 0.05% 2026-03-31
18 UBS Group AG Custodian 886 $1.59K <0.01% 2026-03-31
19 PRICE T ROWE ASSOCIATES INC /MD/ 579,550 $1.01K <0.01% 2026-03-31
20 TD Waterhouse Canada Inc. 448 $790 <0.01% 2026-03-31
21 OSAIC HOLDINGS, INC. Custodian 90 $161 <0.01% 2026-03-31
22 ROYAL BANK OF CANADA Custodian 200 $0 0.00% 2026-03-31
5 filers$23.84M notional
# Filer Notional Value % of Total Period
1 GROUP ONE TRADING LLC Custodian $11.61M 48.72% 2026-03-31
2 IMC-Chicago, LLC Custodian $7.22M 30.27% 2026-03-31
3 SIMPLEX TRADING, LLC Custodian $4.76M 19.95% 2026-03-31
4 MILLENNIUM MANAGEMENT LLC Custodian $155.42K 0.65% 2026-03-31
5 SUMMIT SECURITIES GROUP LLC $97.25K 0.41% 2026-03-31
6 filers$37.22M notional
# Filer Notional Value % of Total Period
1 JPMORGAN CHASE & CO Custodian $11.87M 31.88% 2026-03-31
2 IMC-Chicago, LLC Custodian $10.27M 27.59% 2026-03-31
3 SUMMIT SECURITIES GROUP LLC $5.42M 14.55% 2026-03-31
4 SIMPLEX TRADING, LLC Custodian $5.11M 13.72% 2026-03-31
5 GROUP ONE TRADING LLC Custodian $4.37M 11.73% 2026-03-31
6 a16z Perennial Management, L.P. $195.19K 0.52% 2026-03-31
Insider Activity
Latest: 2026-05-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-28 Anthony Mancini See Remarks Mixed $93.81 -$375.7K EDGAR
2026-04-29 Anthony Mancini See Remarks Mixed $83.02 -$308.2K EDGAR
2026-04-17 MARK A GOLDSMITH See Remarks Mixed $77.35 -$17.46M EDGAR
2026-03-26 Anthony Mancini See Remarks Mixed $64.59 -$2.32M EDGAR
2026-03-19 Xiaolin Wang See Remarks Sell (S) −2,010 $99.48 -$200.0K EDGAR
2026-03-19 Jeff Cislini General Counsel Sell (S) −2,958 $98.68 -$291.9K EDGAR
2026-03-19 Jack Anders Chief Financial Officer Sell (S) −2,753 $99.48 -$273.9K EDGAR
2026-03-19 Margaret A Horn Chief Operating Officer Sell (S) −4,583 $99.48 -$455.9K EDGAR
2026-03-19 MARK A GOLDSMITH See Remarks Sell (S) −12,871 $99.48 -$1.28M EDGAR
2026-03-19 Stephen Michael Kelsey See Remarks Sell (S) −4,302 $99.48 -$428.0K EDGAR
2026-03-19 Lin Wei Chief Medical Officer Sell (S) −2,073 $99.48 -$206.2K EDGAR
2026-03-06 ELIZABETH M ANDERSON Director Gift (G) EDGAR
2026-03-03 Jack Anders Chief Financial Officer Award (A) +20,200 EDGAR
2026-03-03 Jeff Cislini General Counsel Award (A) +14,500 EDGAR
2026-03-03 Margaret A Horn Chief Operating Officer Award (A) +21,100 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
17 insiders · @ $5.94
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Alexis Borisy Director 2,338,884 $13.89M $0 3 2025-06-30
2 Thilo Schroeder Director 760,869 $4.52M $60.00M 1 2024-12-09
3 MARK A GOLDSMITH See Remarks 341,122 $2.03M -$46.94M 29 2026-04-17
4 Stephen Michael Kelsey See Remarks 295,398 $1.75M -$14.95M 24 2026-03-19
5 Margaret A Horn Chief Operating Officer 157,570 $936.0K -$13.15M 17 2026-03-19
6 Jack Anders Chief Financial Officer 125,512 $745.5K -$4.48M 19 2026-03-19
7 Xiaolin Wang See Remarks 116,063 $689.4K -$200.0K 5 2026-03-19
8 Lin Wei Chief Medical Officer 101,366 $602.1K -$600.7K 6 2026-03-19
9 Sandra Horning Director 96,574 $573.6K $0 3 2025-06-30
10 Lorence H. Kim Director 73,090 $434.2K $0 3 2025-06-30
11 Jeff Cislini General Counsel 59,681 $354.5K -$4.18M 29 2026-03-19
12 Anthony Mancini See Remarks 56,821 $337.5K -$4.47M 3 2026-05-28
13 ELIZABETH M ANDERSON Director 35,205 $209.1K $0 4 2026-03-06
14 Flavia Borellini Director 25,024 $148.6K $0 3 2025-06-30
15 Sushil Patel Director 23,090 $137.2K -$445.3K 6 2025-06-30
16 Barbara Weber Director 13,065 $77.6K -$249.7K 4 2024-10-10
17 Frank Clyburn Director 9,738 $57.8K $0 3 2025-06-30
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.